Nextech Invest
Finance · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Bahnhofstrasse 18, Zürich, Zurich, 8001,...Phone Number
+41 443666611Website
www.nextechinvest.comRevenue
$6.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
1
1
1
1
About Nextech Invest
Nextech Invest is a Zurich-based company dedicated to accelerating advancements in precision medicine by identifying transformative cancer medicines. They focus on nurturing emerging biotechnology companies worldwide, particularly during critical moments of scientific validation and value creation. Their services are aimed at supporting the success of these companies in the biotechnology sector. Nextech Invest is committed to fueling the future of healthcare through innovative investments.Explore more
Nextech Invest Org Chart
MM
Partner
MR
Executive Assistant
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nextech Invest your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Nextech Invest had a recent Job posting/layoffs
Check out if Nextech Invest is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Nextech Invest
Product Launch: Get notified when Nextech Invest launches new products
Earning: See what the market has to say on Nextech Invest recently announced quarterly report
Check if Nextech Invest has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Nextech Invest has new funding data
Nextech Invest, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Nextech Invest is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Nextech Invest is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Nextech Invest.
Nextech Invest Tech Stack
A closer look at the technologies used by Nextech Invest
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Nextech Invest News & Media
Be Bio Announces Closing of $92M Series C Financing and Completes Transition to a Multi-Program, Clinical Stage Company
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio” or “the Company”), a leader in B Cell Medicines (BCMs), today announced the closing of its $92M Series C financing. The round includes participation from new investor Nextech with existing investors including ARCH Venture Partners, Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Bristol Myers Squibb, and Takeda Ventures, among others. In conjunction with the financing, Melissa McCracken, Ph.D. of Nextech will joTubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline
MUNICH, Germany--(BUSINESS WIRE)--Tubulis today announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. The round was co-led by EQT Life Sciences and Nextech Invest Ltd, on behalf of one or more funds managed by it, with participation from new US-based funds, Frazier Life Sciences and Deep Track Capital as well as all existing investors, including Andera Partners, BioMedPartners, Fund+, Bayern Kapital (with ScaleUp-Fonds Bayern), EMariana Oncology Raises USD175M in Series B Funding
Mariana Oncology, a Watertown MA-based fully integrated, next-generation radiopharmaceuticals company, raised $175m in Series B financing. The round was co-led by Forbion (the first investment by its Forbion Ventures Fund VI,) and Deep Track Capital, with participation from founding investors Atlas Venture, Access Biotechnology and RA Capital Management, and new investors Nextech Invest, Surveyor Capital […] The post Mariana Oncology Raises USD175M in Series B Funding appeared first on FinSMEs.K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14)
Funds raised will be used to demonstrate clinical validation and proof-of-concept in t(4;14) multiple myeloma with KTX-1001 monotherapy and KTX-1001 combination regimens with existing standard-of-care agents CAMBRIDGE, Mass., June 28, 2023 /PRNewswire/ -- K36 Therapeutics ("K36"), a...
Read more news
Top Finance Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nextech Invest
Sign Up For FreeTo access detailed company insights
Nextech Invest is a Zurich-based company dedicated to accelerating advancements in precision medicine by identifying transformative cancer medicines. They focus on nurturing emerging biotechnology companies worldwide, particularly during critical moments of scientific validation and value creation. Their services are aimed at supporting the success... Read More
